GGrantIndex
Sort

78,016 grants matching breast cancer

Network Lead Academic Participating Site Grant from the Roswell Cancer Inst.

$616,000
Ellis G Levine · Roswell Park Cancer Institute Corp · U10 · FY2016 · CA

MICRO-INSTRUMENT PLATFORMS FOR GENETIC-BASED ANALYSES

$615,987
Louisiana State Univ A&M Col Baton Rouge · R24 · FY2004 · EB

Longitudinal investigation of sociocultural and behavioral influences on symptom management, biological response, and functioning between Chinese and White breast cancer survivors.

$615,979
Judy Huei-Yu Wang · Georgetown University · R01 · FY2023 · CA

Genomic and Translational Approaches to Neuroendocrine Switching Events

$615,950
Michael G Rosenfeld · University Of California, San Diego · R37 · FY2013 · DK

Environmental Chemical Body Burden and Prospective Breast Cancer Risk in the Cancer Prevention Study-3 Cohort

$615,930
Susan L. Neuhausen · Beckman Research Institute/City Of Hope · R01 · FY2025 · ES

Uncoupling obesity from breast cancer in African American women

$615,920
Gerald V Denis · Boston University Medical Campus · U01 · FY2015 · CA

Diversity of the Tumor Microenvironment in Cancer Progression and Metastasis

$615,883
Christina S Leslie · Sloan-Kettering Inst Can Research · U54 · FY2014 · CA

Design and characterization of bacterial population dynamics in solid tumor models

$615,868
Jeff M Hasty · University Of California, San Diego · R01 · FY2024 · EB

LEGACY: A cohort of youth in families from the Breast Cancer Family Registry

$615,841
Mary Beth Terry · Columbia University Health Sciences · R01 · FY2013 · CA

IL-2 Family Cytokines and their Receptors--Biology of the IL-7/TSLP Systems

$615,820
Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL

Identifying senescence and immune biomarkers predictive of benefit to combined CDK4 and checkpoint blockade inhibition in patients with dedifferentiated liposarcoma

$615,811
Sandra P D'angelo · Sloan-Kettering Inst Can Research · R01 · FY2023 · FD

Par-4 Regulation of Actomyosin Contractility as a Tumor Suppressive Mechanism in Breast Cancer

$615,796
James V Alvarez · Fred Hutchinson Cancer Center · R01 · FY2025 · CA

Determinants of breast tissue composition in young women

$615,763
Norman F Boyd · University Health Network · R01 · FY2010 · CA

DRUG DISCOVERY CORE FACILITY (DDCF)

$615,763
Kinfe Ken Redda · Florida Agricultural And Mechanical Univ · G12 · FY2009 · RR

Registering Cancer Recurrences in the Georgia Cancer Registry

$615,744
Kevin C Ward · Emory University · R01 · FY2019 · CA

Nrf2 Regulation of Ductal Pancreatic Cancer Etiology and Treatment Response

$615,683
David Tuveson · Cold Spring Harbor Laboratory · R01 · FY2018 · CA

Evaluating an evidence-based family history screening program adapted to increase reach and uptake of screening for BRCA-associated cancers in rural public health clinics

$615,683
Yue Guan · Emory University · R37 · FY2023 · CA

Nrf2 Regulation of Ductal Pancreatic Cancer Etiology and Treatment Response

$615,683
David Tuveson · Cold Spring Harbor Laboratory · R01 · FY2020 · CA

Nrf2 Regulation of Ductal Pancreatic Cancer Etiology and Treatment Response

$615,683
David Tuveson · Cold Spring Harbor Laboratory · R01 · FY2021 · CA

Development of Virtual Tumor

$615,609
Massachusetts General Hospital · U56 · FY2005 · CA

Acceptance and Commitment Therapy for Fear of Recurrence in Breast Cancer Survivors

$615,609
Shelley A. Johns · Indiana University Indianapolis · R01 · FY2022 · CA

Lifestyle and Molecular Factors of Bone Health in Breast Cancer Survivors

$615,578
Marilyn L Kwan · Kaiser Foundation Research Institute · R01 · FY2014 · CA

Antioxidant supplements, genetics, and chemotherapy outcomes

$615,542
Christine B. Ambrosone · Roswell Park Cancer Institute Corp · R01 · FY2009 · CA

Early Stage Investigator Recruitment in Cancer Research

$615,426
Henry Shelton Earp · Univ Of North Carolina Chapel Hill · P30 · FY2009 · CA

Early Stage Investigator Recruitment in Cancer Research

$615,426
Henry Shelton Earp · Univ Of North Carolina Chapel Hill · P30 · FY2010 · CA